Biomea Financial Statements From 2010 to 2026

BMEA Stock  USD 1.30  0.03  2.36%   
Biomea Fusion's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Biomea Fusion's valuation are provided below:
Market Capitalization
91.9 M
Earnings Share
(2.25)
We have found one hundred twenty available fundamental signals for Biomea Fusion, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Biomea Fusion prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. The current year's Market Cap is expected to grow to about 212 M. The current year's Enterprise Value is expected to grow to about 118.3 M
Check Biomea Fusion financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biomea Fusion's main balance sheet or income statement drivers, such as Net Interest Income of 6.8 M, Interest Income of 6.8 M or Depreciation And Amortization of 2.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.57. Biomea financial statements analysis is a perfect complement when working with Biomea Fusion Valuation or Volatility modules.
  
Build AI portfolio with Biomea Stock
Check out the analysis of Biomea Fusion Correlation against competitors.
For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.

Biomea Fusion Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets120.6 M91.9 M51.3 M
Slightly volatile
Other Current Liabilities6.5 M7.7 M2.9 M
Slightly volatile
Total Current Liabilities12.9 M24.9 M6.5 M
Slightly volatile
Accounts Payable15.6 M14.9 M3.6 M
Slightly volatile
Cash101.7 M67 M42.7 M
Slightly volatile
Cash And Short Term Investments107 M67 M44.7 M
Slightly volatile
Common Stock Total Equity2.2 K3.5 K1.7 K
Slightly volatile
Common Stock Shares Outstanding26.5 M41.5 M18.2 M
Slightly volatile
Liabilities And Stockholders Equity120.6 M91.9 M51.3 M
Slightly volatile
Non Current Liabilities Total9.9 MM5.5 M
Slightly volatile
Other Current Assets12.1 M11.6 M2.6 M
Slightly volatile
Other Stockholder Equity529.9 M504.6 M141.3 M
Slightly volatile
Total Liabilities26.5 M32.6 M12.1 M
Slightly volatile
Total Current Assets110.8 M78.6 M46.8 M
Slightly volatile
Capital Stock2.9 K4.6 K1.9 K
Slightly volatile
Common Stock2.9 K4.6 K1.9 K
Slightly volatile
Short and Long Term Debt Total5.4 M10.1 M2.5 M
Slightly volatile
Non Currrent Assets Other1.1 M1.1 M840.3 K
Slightly volatile
Short and Long Term Debt28.8 K32.4 K35.4 K
Slightly volatile
Short Term Debt1.3 M2.4 M722.6 K
Slightly volatile
Property Plant Equipment4.3 M6.7 M2.2 M
Slightly volatile
Current Deferred Revenue1.8 MM2.2 M
Slightly volatile
Capital Surpluse257.8 M276.1 M235.1 M
Slightly volatile
Non Current Liabilities Other1.6 M1.5 M2.1 M
Slightly volatile

Biomea Fusion Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income6.8 M6.5 M1.8 M
Slightly volatile
Depreciation And Amortization2.1 MM498.1 K
Slightly volatile
Selling General Administrative15.8 M29.9 M7.8 M
Slightly volatile
Other Operating Expenses174 M165.7 M44.3 M
Slightly volatile
Research Development142.6 M135.8 M35.5 M
Slightly volatile
Total Operating Expenses174 M165.7 M44.3 M
Slightly volatile
Cost Of Revenue1.8 MM791.3 K
Slightly volatile
Non Operating Income Net Other1.4 M1.6 M1.8 M
Slightly volatile
Selling And Marketing Expenses3.4 M3.8 M4.1 M
Slightly volatile

Biomea Fusion Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow214 M203.8 M53.9 M
Slightly volatile
Other Cashflows From Financing Activities1.4 M1.5 M17.5 M
Pretty Stable
Depreciation2.1 MM543.5 K
Slightly volatile
Other Non Cash Items2.8 M5.3 M1.4 M
Slightly volatile
Capital Expenditures395.5 K416.3 K547.4 K
Slightly volatile
Total Cash From Financing Activities1.8 M1.9 M23.8 M
Slightly volatile
End Period Cash Flow101.9 M67.4 M42.8 M
Slightly volatile
Change To Netincome12.5 M11.9 MM
Slightly volatile
Sale Purchase Of Stock1.1 M1.1 M108.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation1.492.01.0004
Slightly volatile
Payables Turnover0.140.160.1779
Slightly volatile
Cash Per Share1.381.451.5735
Slightly volatile
Days Payables Outstanding1.6 K1.8 KK
Slightly volatile
Income Quality0.961.00.987
Slightly volatile
Net Debt To EBITDA0.380.41.239
Pretty Stable
Current Ratio3.443.636.4709
Slightly volatile
Debt To Equity0.160.150.0664
Slightly volatile
Capex Per Share0.0110.01150.0207
Slightly volatile
Interest Debt Per Share0.120.220.0793
Slightly volatile
Debt To Assets0.10.09880.0258
Slightly volatile
Days Of Payables Outstanding1.6 K1.8 KK
Slightly volatile
Ebt Per Ebit1.081.11.0042
Pretty Stable
Total Debt To Capitalization0.140.130.0608
Slightly volatile
Debt Equity Ratio0.160.150.0664
Slightly volatile
Quick Ratio3.443.636.4709
Slightly volatile
Cash Ratio2.943.095.8945
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.151.0323
Slightly volatile
Debt Ratio0.10.09880.0258
Slightly volatile

Biomea Fusion Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap212 M126.1 M197.2 M
Pretty Stable
Enterprise Value118.3 M81.5 M69.1 M
Slightly volatile

Biomea Fundamental Market Drivers

Biomea Upcoming Events

26th of March 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Biomea Fusion Financial Statements

Biomea Fusion stakeholders use historical fundamental indicators, such as Biomea Fusion's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biomea Fusion investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biomea Fusion's assets and liabilities are reflected in the revenues and expenses on Biomea Fusion's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Biomea Fusion. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred RevenueM1.8 M
Cost Of RevenueM1.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Biomea Fusion offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomea Fusion's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomea Fusion Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomea Fusion Stock:
Check out the analysis of Biomea Fusion Correlation against competitors.
For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomea Fusion. If investors know Biomea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomea Fusion listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.25)
Return On Assets
(0.75)
Return On Equity
(2.09)
The market value of Biomea Fusion is measured differently than its book value, which is the value of Biomea that is recorded on the company's balance sheet. Investors also form their own opinion of Biomea Fusion's value that differs from its market value or its book value, called intrinsic value, which is Biomea Fusion's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomea Fusion's market value can be influenced by many factors that don't directly affect Biomea Fusion's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomea Fusion's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomea Fusion is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomea Fusion's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.